Clinical reference Biomarker Directory
Back to directory

LHB

Established

LH, paired with FSH, helps evaluate PCOS, fertility timing, and menopause, though its role in routine menopause diagnosis is narrowing.

Also known as LH luteinizing hormone
In plain language

LH triggers ovulation in women and testosterone production in men. It's often measured alongside FSH to help evaluate fertility, PCOS, or menopause, though for straightforward menopause symptoms, doctors increasingly rely on symptoms alone rather than hormone levels.

Biomarker & context

LHB encodes the beta subunit of luteinizing hormone (LH), a pituitary hormone that triggers ovulation in women and stimulates testosterone production in men.

What it indicates

LH is used alongside FSH to evaluate menstrual cycle timing, polycystic ovary syndrome (PCOS, where an elevated LH:FSH ratio is a classic supporting finding), and menopause, as well as male hypogonadism evaluation.

Diagnosis & clinical testing

Measured via serum immunoassay, often timed to a specific point in the menstrual cycle for fertility evaluation; a mid-cycle LH surge is also detected by home ovulation predictor kits.

Guiding treatment

As with FSH, current guidelines increasingly de-emphasize routine hormone testing for typical menopause diagnosis in favor of clinical symptoms alone; LH remains more clinically useful in PCOS evaluation and fertility timing.

Clinical significance

An elevated LH:FSH ratio is a classic supporting (though not required) finding in PCOS.

References
  1. General reproductive endocrinology reference literature on LH in PCOS, fertility, and menopause evaluation.